Joe Pickrell, CEO - Jan 01, 2023
2022 Gencove year in review
Maximillian Rozenblum, Applied Bioinformatics Engineer - Nov 10, 2022
New species: salmon
New pipeline available: salmon
Zlatko Mašek - Nov 03, 2022
Importing samples from existing projects
Samples already on the Gencove platform can now be easily reprocessed using a different project configuration.
Forest Dussault, Software Engineer - Nov 01, 2022
Processing deep sequencing data with the Gencove platform
To help move towards Gencove’s vision of ubiquitous sequencing, we’re happy to announce support for our deep whole genome sequencing (WGS) pipeline!
David Neuman, Head of Plant and Animal Genomics Sales - Aug 25, 2022
A Genotyping Platform that Changes with Your Breeding Program
Invest in a genotyping solution that changes with your breeding program. The Gencove platform ensures backward compatibility, adaptability to new markers and reference genomes, additional analyses, and continual innovation.
David Neuman, Head of Plant and Animal Genomics Sales - Aug 23, 2022
The Importance of Speed in Plant and Animal Breeding
Improve molecular breeding efficiency with a modern genotyping approach that can be set up in a few weeks plus turns your samples around quickly!
Jesse Hoff, Agrigenomics Product Manager - Jul 06, 2022
Get the Utility of Sequencing at the Cost of a Microarray
Gencove’s low-pass sequencing platform is at cost-per-sample price parity with many microarray assays across a wide range of species in both plants and animals. That makes Gencove the best choice for getting the utility of sequencing data at microarray prices.
Jesse Hoff, Agrigenomics Product Manager - Jun 15, 2022
A Modern Approach to Genotyping for Plant and Animal Breeding
There’s no question that sequencing is a powerhouse of utility for genetics in breeding. However, does it meet the requirements to become a routine tool for genomic selection in breeding programs?
Josh Setton, Head of Sales - Jun 09, 2022
Three Ways Gencove’s Low-Pass Whole Genome Sequencing is Modernizing the Drug Discovery Process
Pharmaceutical companies use Whole Exome Sequencing (WES) in their drug discovery and development process. However, R&D teams still need a comprehensive view of genomic variation outside the exome. Historically, the only way to augment WES was with arrays, but now pharma companies have an alternative - low-pass whole genome sequencing.
Jesse Hoff, Agrigenomics Product Manager - Jun 02, 2022
The First EPD for Bovine Congestive Heart Failure from Simplot and Gencove
The Simplot and Gencove genomic EPD provides a benchmark from which bulls can be evaluated for cardiac morphology significantly reducing their calves’ morbidity and mortality and increasing their overall economic performance.
Kristi Ashton, Head of Marketing - Jun 01, 2022
Gencove and Element Biosciences, Inc., Reduce the Cost and Complexity of Obtaining Genomic Information
To offer another option for scientists and companies seeking whole genome sequencing and analysis, Gencove evaluated the ability to process low-pass sequencing data derived from the AVITI™ System in two studies.
Jesse Hoff, Agrigenomics Product Manager - May 12, 2022
Introducing InfiniSEEK - Low-pass Genotyping Plus Target Capture in One Assay
Whether it is genotyping a whole herd or building support for new species and breeds, at Gencove, we’re continually looking for ways to empower companies and scientists to discover more using sequencing. That’s why we’re excited to share the latest milestone in this pursuit with the launch of InfiniSEEK™– available now through NEOGEN.